Robin Fastenau

Consumer Services

Health Technology

Retail Trade

Profile

Robin Fastenau worked as a Director of Investor Relations at Triangle Pharmaceuticals, a Director of Corporate Communications at BMC East LLC and Stock Building Supply Holdings, a Director of Global Pipeline Communications at GlaxoSmithKline LLC, a Manager of Investor Relations and Communications at Trimeris, and a VP of Corporate Communications and Investor Relations at Metabolon, Inc. Fastenau holds a Master's in Business Administration from Wake Forest University and an undergraduate degree from Meredith College.

Former positions of Robin Fastenau

Companies	Position	End
Stock Building Supply Holdings, Inc. Stock Building Supply Holdings, Inc. Home Improvement ChainsRetail Trade Stock Building Supply Holdings, Inc. is a diversified lumber and building materials distributor and solutions provider that sell to new construction and repair and remodel contractors. The company primary products are lumber & lumber sheet goods, millwork, doors, flooring, windows, structural components, such as engineered wood products, trusses, wall panels and other exterior products. It provides solution-based services to its customers, including design, product specification and installation management services. The company serves a broad customer base, including large-scale production homebuilders, custom homebuilders and repair and remodeling contractor. It was formerly known as Saturn Acquisition Holdings LLC and changed its name to Stock Building Supply Holdings, Inc. in May 2013. The company's business roots back to 1922. Stock Building Supply Holdings was founded on April 16, 2009 and is headquartered in Raleigh, NC.	Investor Relations Contact	30/04/2011
Triangle Pharmaceuticals, Inc. Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC.	Investor Relations Contact	-
Trimeris, Inc. Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.	Investor Relations Contact	-
GlaxoSmithKline LLC GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.	Corporate Officer/Principal	-
Metabolon, Inc. Metabolon, Inc. Packaged SoftwareTechnology Services Metabolon, Inc. operates as a health technology company. It offers precision medicine, clinical diagnostic, and metabolomics services. The firm serves to the pharmaceutical, biotechnology, consumer product industries. The company was founded in 2000 and is headquartered in Morrisville, NC.	Investor Relations Contact	-

See the detail of Robin Fastenau's experience

Training of Robin Fastenau

Meredith College	Undergraduate Degree
Wake Forest University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies